DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Vanderlaan BF. et al.
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer.

The American journal of managed care 2011;
17: 455-464

Download Bibliographical Data

Access: